← Leaderboards
Michelle Sharp
Johns Hopkins University
$902,267
Attributed
$935,600
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $227.1K · FY2021–25$250K$187.5K$125K$62.5K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$935,600 · 2
By mechanism
K23$885,600 · 1
R13$50,000 · 1
Top collaborators
- Nisha Aggarwal Gilotra1 shared
- Carlos A Pardo-Villamizar1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Petros C Karakousis$19,415,784
- Sinead Delany-Moretlwe$2,447,389
- Meredith C McCormack$14,784,022
- Gregory D Kirk$60,349,977
- Elizabeth Ann Sugar$11,501,247
Others in their field
Other Emerging Leaders on “Side Effect”
- Jeffrey Reich · Sparian Biosciences, Inc.$13,729,307
- Jacob D Estes · Oregon Health & Science University$9,581,486
- James N Campbell · Centrexion Therapeutics Corporation$8,662,635
- Gary Fanger · Rise Therapeutics, Llc$8,225,136
- Katherine Teresa Mills · Tulane University Of Louisiana$7,657,098
- Warren David Lo · Virginia Polytechnic Inst And St Univ$7,249,509
Research focus
Side EffectOralNeurologicSarcoidosisSolidOrganImpairmentMorbidity - Disease RatePulmonary FibrosisPulmonary HypertensionSudden DeathUnited StatesPulmonary Heart DiseaseFutureAffectHealth DisparityMental DepressionCaringBeliefBehavior TherapyEvidence BaseBehavioralAfrican American PopulationEmergency Department Visit
Grant awards (6)
Medication Adherence and Clinical Outcomes in Sarcoidosis$177,120
K23 · FY2025 · HL · contact PI
Medication Adherence and Clinical Outcomes in Sarcoidosis$177,120
K23 · FY2024 · HL · contact PI
Americas Association of Sarcoidosis and Other Granulomatous Disorders 2024: The Art of Working Together for Progress$50,000
R13 · FY2024 · HL · contact PI
Medication Adherence and Clinical Outcomes in Sarcoidosis$177,120
K23 · FY2023 · HL · contact PI
Medication Adherence and Clinical Outcomes in Sarcoidosis$177,120
K23 · FY2022 · HL · contact PI
Medication Adherence and Clinical Outcomes in Sarcoidosis$177,120
K23 · FY2021 · HL · contact PI